Cite
HARVARD Citation
Lim, D. et al. (2021). Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab. Medical journal of Australia. 215 (9), p. 435. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lim, D. et al. (2021). Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab. Medical journal of Australia. 215 (9), p. 435. [Online].